Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 211

    1.

    Human insulin analog--induced lipoatrophy.

    Lopez X, Castells M, Ricker A, Velazquez EF, Mun E, Goldfine AB.

    Diabetes Care. 2008 Mar;31(3):442-4. Epub 2007 Dec 27.PMID: 18162498 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Lipoatrophy induced by recombinant human insulin injection.

    Murao S, Hirata K, Ishida T, Takahara J.

    Intern Med. 1998 Dec;37(12):1031-3.PMID: 9932635 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    A case of lipoatrophy with insulin detemir.

    Del Olmo MI, Campos V, Abellán P, Merino-Torres JF, Piñón F.

    Diabetes Res Clin Pract. 2008 Apr;80(1):e20-1. Epub 2008 Feb 20.PMID: 18281121 [PubMed - indexed for MEDLINE]Related articles

    4.

    Lispro insulin-induced lipoatrophy: a new case.

    Al-Khenaizan S, Al Thubaiti M, Al Alwan I.

    Pediatr Diabetes. 2007 Dec;8(6):393-6.PMID: 18036067 [PubMed - indexed for MEDLINE]Related articles

    5.

    Lipoatrophy is a thing of the past, or is it?

    Hussein SF, Siddique H, Coates P, Green J.

    Diabet Med. 2007 Dec;24(12):1470-2. Epub 2007 Nov 1.PMID: 17976201 [PubMed - indexed for MEDLINE]Related articles

    6.

    Lipodystrophy reactions to insulin: effects of continuous insulin infusion and new insulin analogs.

    Radermecker RP, Piérard GE, Scheen AJ.

    Am J Clin Dermatol. 2007;8(1):21-8. Review.PMID: 17298103 [PubMed - indexed for MEDLINE]Related articles

    7.

    "Lipoblastoma-like" lipoatrophy induced by human insulin: morphological evidence for local dedifferentiation of adipocytes?

    Jermendy G, Nádas J, Sápi Z.

    Diabetologia. 2000 Jul;43(7):955-6. No abstract available. PMID: 10952472 [PubMed - indexed for MEDLINE]Related articles

    8.

    [Lipoatrophy associated with rapid-acting insulin analogues in young patients with type 1 diabetes mellitus]

    Szypowska A, Skórka A, Pańkowska E.

    Pediatr Endocrinol Diabetes Metab. 2008;14(2):117-8.PMID: 18721499 [PubMed - indexed for MEDLINE]Related articles

    9.

    Insulin allergy and extensive lipoatrophy in child with type 1 diabetes.

    Beltrand J, Guilmin-Crepon S, Castanet M, Peuchmaur M, Czernichow P, Levy-Marchal C.

    Horm Res. 2006;65(5):253-60. Epub 2006 Mar 14.PMID: 16582568 [PubMed - indexed for MEDLINE]Related articles

    10.

    [Human insulin-induced lipoatrophy]

    Jermendy G, Nádas J, Sápi Z.

    Orv Hetil. 2000 Oct 29;141(44):2393-6. Hungarian. PMID: 11105557 [PubMed - indexed for MEDLINE]Related articles

    11.

    Human insulin-induced lipoatrophy.

    Felner EI.

    J Pediatr. 2003 Apr;142(4):448. No abstract available. PMID: 12712066 [PubMed - indexed for MEDLINE]Related articles

    12.

    [Insulin-induced lipoatrophy--caused by monocomponent insulin?]

    Gyimesi A, Iványi J.

    Orv Hetil. 1989 Dec 17;130(51):2751-2. Hungarian. PMID: 2689957 [PubMed - indexed for MEDLINE]Related articles

    13.

    Human insulin-induced lipoatrophy. Successful treatment using a jet-injection device.

    Logwin S, Conget I, Jansa M, Vidal M, Nicolau C, Gomis R.

    Diabetes Care. 1996 Mar;19(3):255-6. Erratum in: Diabetes Care 1997 Jan;20(1):119. PMID: 8742573 [PubMed - indexed for MEDLINE]Related articles

    14.

    A case of lipoatrophy with Lispro insulin without insulin pump therapy.

    Arranz A, Andia V, López-Guzmán A.

    Diabetes Care. 2004 Feb;27(2):625-6. No abstract available. PMID: 14747261 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Insulin-induced lipoatrophy: evidence for an immune pathogenesis.

    Reeves WG, Allen BR, Tattersall RB.

    Br Med J. 1980 Jun 21;280(6230):1500-3.PMID: 6992934 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Human recombinant DNA insulin-induced lipoatrophy in a patient with type 2 diabetes mellitus.

    Mu L, Goldman JM.

    Endocr Pract. 2000 Mar-Apr;6(2):151-2.PMID: 11421532 [PubMed - indexed for MEDLINE]Related articles

    17.

    The increase in tryptase- and chymase-positive mast cells is associated with partial inactivation of chymase and increase in protease inhibitors in basal cell carcinoma.

    Diaconu NC, Kaminska R, Naukkarinen A, Harvima RJ, Harvima IT.

    J Eur Acad Dermatol Venereol. 2007 Aug;21(7):908-15.PMID: 17658999 [PubMed - indexed for MEDLINE]Related articles

    18.

    [Lipoatrophy after use of long acting insulin glargine analogue in a 32-year-old patient with type 1 diabetes]

    Dziura M, Wasikowa R.

    Pediatr Endocrinol Diabetes Metab. 2008;14(1):61-3. Polish. PMID: 18577350 [PubMed - indexed for MEDLINE]Related articles

    19.

    Lipoatrophy associated with lispro insulin in insulin pump therapy: an old complication, a new cause?

    Griffin ME, Feder A, Tamborlane WV.

    Diabetes Care. 2001 Jan;24(1):174. No abstract available. PMID: 11194227 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    [Tryptase- and chymase-positive mast cells as possible prognostic factor in patients with Hodgkin's lymphoma]

    Rygoł B, Kyrcz-Krzemień S, Pajiak J, Konicki P, Kowai E, Gasińska T.

    Pol Arch Med Wewn. 2007 Jan-Feb;117(1-2):27-32. Polish. PMID: 17642203 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data